CureVac
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $493,902 | $14,436 | $12,373 | $22,567 |
Gross Profit | 471,971 | -26,287 | -29,316 | -31,030 |
EBITDA | 375,225 | -65,962 | -72,221 | |
EBIT | 370,713 | -71,088 | -77,350 | |
Net Income | 338,043 | -72,543 | -70,553 | -86,653 |
Net Change In Cash | 493,902 | 14,436 | 12,373 | 22,567 |
Free Cash Flow | 350,781 | -96,252 | -101,642 | -58,014 |
Cash | 550,862 | 202,515 | 300,152 | 402,452 |
Basic Shares | 225,362 | 224,313 | 224,291 | 223,988 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $53,758 | $67,420 | $102,990 | $48,900 |
Gross Profit | -70,608 | -116,573 | -135,205 | 34,727 |
EBITDA | -234,090 | -209,386 | -386,486 | -123,095 |
EBIT | -257,476 | -235,547 | -422,364 | -136,706 |
Net Income | -260,167 | -249,029 | -411,716 | -129,074 |
Net Change In Cash | 53,758 | 67,420 | 102,990 | 48,900 |
Free Cash Flow | -323,087 | -379,399 | -861,029 | 475,051 |
Cash | 402,783 | 495,797 | 811,464 | 1,322,593 |
Basic Shares | 220,833 | 189,074 | 186,012 | 132,195 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $1.50 |
2024-06-30 | -$0.34 |
2024-03-31 | -$0.39 |
2023-12-31 | -$0.42 |
